Wounds and InjuriesNCT02724007
Does an International Version of ICISS Predict Mortality for Patients Admitted With Trauma in Four Public University Hospitals in Urban India?
An observational study of Wounds and Injuries, run by Martin Gerdin.
Trial summary
The aim of this study is to validate international versions of the International Classification of Disease Injury Severity Score (ICISS) in adult trauma patients admitted to four public university hospitals in urban India. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Wounds and Injuries
- How many people
- 16,047 participants
- Where
- No sites listed yet
- Study dates
- Jan 2016to Jan 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: The study population is patients admitted with a history of trauma in any of the study centers, or patients who died between arrival and admission. Patients who were dead on arrival to the hospital were excluded. Patients with isolated limb fractures without vascular injuries were excluded, due to the administration of these patients in the study centers.
Who may be able to join
- History of trauma or death between arrival and admission
Who cannot join
- Isolated limb fractures without vascular injury
About this study
The aim of this study is to validate international versions of the International Classification of Disease Injury Severity Score (ICISS) in adult trauma patients admitted to four public university hospitals in urban India.
Read the detailed description
Introduction
Trauma causes 10% of the world's annual deaths. Trauma-related deaths are most common in low- and middle-income countries, which accounts for over 90% of global trauma mortality. In 2013 over 1.2 million trauma deaths occurred in India alone. Hence, India accounted for 25% of trauma-related deaths worldwide. Experiences from high income countries show that the establishment of trauma registers have been of importance for the improvement of trauma care and research, allowing for comparisons between different hospitals as well as over time.
To be useful such comparisons should be risk-adjusted to account for differences in care and patient case mix. In trauma one of the most important patient case mix characteristics to adjust for is injury severity. Several different injury severity scores exist for this purpose. One of these scores is the International Classification of Disease Injury Severity Score (ICISS). In contrast to other established scores, such as the Injury Severity Score (ISS), ICISS can be calculated based on injuries coded using ICD for administrative purposes, making it cost effective.
The validity of ICISS has primarily been studied in high-income countries ICISS requires an empirically estimated Survival Risk Ratio (SRR) for each ICD code. Some studies from high income countries has shown similar predictive performance of ICISS when using SRRs derived from other high-income countries. However, the generalisability of such SRRs to low- and middle-income countries such as India has not been researched. Therefore, the aim of this study was to validate an international version of ICISS in patients presenting with trauma to four public university hospitals in urban India.
Study design
Data from a multi-centre cohort study will be used.
Setting
Data from the Towards Improved Trauma Care Outcomes (TITCO) in India project will be used, which was conducted at four public university hospitals in urban India. The four centres were Lokmanya Tilak Municipal General Hospital in Mumbai, King Edward Memorial Hospital in Mumbai, Jai Prakash Narayan Apex Trauma Center in Delhi, and the Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital in Kolkata.
Data was collected between October 2013 and September 2015. Patient data was collected by one project officer in every study center. The project officer worked eight hour shifts per day, with a rotating schedule between day and night shifts. All project officers had at least a health science master degree, and were continuously trained and supervised by project management. Details on the data collection process has been published elsewhere.
Source and method of participant selection
Eligible patients were identified by project officers through direct observation in the emergency room and/or through extraction from patient records. Data from patients admitted outside of the shifts was collected retrospectively within days. Patients were followed up until discharge, death, or 30 days, whichever occurred first. Patients transferred to other hospitals were considered as discharged.
Covariates
The explanatory variable will be ICISS. Other covariates include age, sex, mechanism of injury, mode of transportation and transfer status. These covariates will be used to characterise the study sample.
Data sources/measurements
Patient outcomes was followed up at 30 days, death in hospital or discharge, whichever occurred first. Patients discharged alive before 30 days were considered to be alive at 30 days after arrival to the hospital. ICISS will be assigned based on ICD-coding of the free text injury descriptions, using the 10th revision of the World Health Organization's International Classification of Diseases (ICD-10). Survival Risk Ratios from two published data sets will be used. One of the data sets had SRRs calculated from an Australian and New Zealand population (14). The other had SRRs created by pooling data from Australia, Argentina, Austria, Canada, Denmark, New Zealand and Sweden (12). Final ICISS for patients with multiple injuries will be calculated by multiplying the SRRs for all ICD codes assigned to the patient.
Bias
All patients matching the selection criteria will be included in the study. All data was collected from patient records and examinations done by hospital personnel with no association to the study. The data collectors worked independently form the project managers. The free text injury descriptions will be extracted from the data set and assigned ICD-codes with no other data available, including data on patient outcome.
Study size
The sample size required is calculated to give an 80% power to detect substantial differences in model performance such as 1.5 times too high or low predicted survival probability. The calculations were based on published recommendations on the sample size needed to detect such differences in the external validity of prediction models with a binary outcome. Based on these recommendations, the sample size needed to include 100 consecutive events, i.e. in-hospital deaths within 24 hours and all non-events enrolled during the same period, was calculated. In-hospital mortality within 24 hours was used for the sample size calculation to power the study for secondary outcomes as well.
Quantitative variables
All quantitative variables will be analysed as continuous.
Statistical methods and analyses
R will be used for all statistical analyses. A confidence level of 95% and a significance level of 5% will be used. For each patient one ICISS will be calculated for each of the two sets of SRR referenced above. Henceforth, the ICISS based on SRR from Australia and New Zealand will be denoted ICISS-ANZ, and the ICISS based on the international SRR derived by Gedeborg et al. will be denoted ICISS-I. The performance of ICISS-ANZ and ICISS-I in predicting death within 30 days and death within 24 hours will be estimated in terms of discrimination and calibration.
The area under the receiver operating characteristics curve (AUROCC) will be used as a measure of discrimination. Calibration will be assessed visually by plotting observed versus predicted outcomes and will be quantified by calculating a calibration slope. The main analysis will be a complete case analysis in which only patients with complete data on outcomes and covariates will be included. Both ICISS-ANZ and ICISS-I will be based only on SRR calculated from ICD-10 codes that occurred in at least 20 patients in respective derivation dataset. Patients without any injury reported will be assigned an ICISS of 1.
Sensitivity analyses Four sensitivity analyses will be conducted. The first sensitivity analysis will include patients with missing data on covariates but with complete outcome data. The second sensitivity analysis will exclude patients without any reported injury. The third sensitivity analysis will include all SRR regardless of the number of occurrences in the original derivation datasets. In the final sensitivity analysis the ICISS for each patient will be based only on unique ICD-10 codes, in other words, each ICD-10 code was only allowed to contribute one SRR to ICISS even if it occurred more than once in the same patient.
- Conditions
- Wounds and Injuries
- Keywords
- Trauma, India, ICISS
- Medical subject headings
- Wounds and Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| All participants | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mortality
Measured: Within 30 days of patient arrival to participating centre
Secondary outcomes (1)
Mortality
Measured: Within 24 hours of patient arrival to participating centre
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Mar 2016 (estimated)
- Study startJan 2016
- Primary completionJan 2017
- Study completionJan 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Wounds and InjuriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 16,047 participants (actual)
Sponsor and investigators
- Lead sponsor
- Martin Gerdin
- Sponsor type
- University, hospital or other
- Collaborators
- Lokmanya Tilak Municipal Medical College and Hospital, King Edward Memorial Hospital, Jai Prakash Narayan Apex Trauma Center, Seth Sukhlal Karnani Memorial Hospital, Tata Institute of Social Sciences
- Responsible party
- Sponsor-investigator, Martin Gerdin, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02724007
- Sponsor's protocol ID
- alice-claeson-201603271932
- Status last verified
- Feb 2017
- First submitted
- 27 Mar 2016
- Last updated
- 28 Feb 2017
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does an International Version of ICISS Predict Mortality for Patients Admitted With Trauma in Four Public University Hospitals in Urban India?
- ClinicalTrials.gov ID
- NCT02724007
- Acronym / sponsor ID
- alice-claeson-201603271932
- Conditions
- Wounds and Injuries
- Keywords
- Trauma, India, ICISS
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 16,047 participants (actual)
- Lead sponsor
- Martin GerdinUniversity, hospital or other
- Collaborators
- Lokmanya Tilak Municipal Medical College and Hospital, King Edward Memorial Hospital, Jai Prakash Narayan Apex Trauma Center, Seth Sukhlal Karnani Memorial Hospital, Tata Institute of Social Sciences
- Study start
- Jan 2016
- Primary completion
- Jan 2017 (actual)
- Study completion
- Jan 2017 (actual)
- First posted
- 31 Mar 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to validate international versions of the International Classification of Disease Injury Severity Score (ICISS) in adult trauma patients admitted to four public university hospitals in urban India.
Detailed description
Introduction
Trauma causes 10% of the world's annual deaths. Trauma-related deaths are most common in low- and middle-income countries, which accounts for over 90% of global trauma mortality. In 2013 over 1.2 million trauma deaths occurred in India alone. Hence, India accounted for 25% of trauma-related deaths worldwide. Experiences from high income countries show that the establishment of trauma registers have been of importance for the improvement of trauma care and research, allowing for comparisons between different hospitals as well as over time.
To be useful such comparisons should be risk-adjusted to account for differences in care and patient case mix. In trauma one of the most important patient case mix characteristics to adjust for is injury severity. Several different injury severity scores exist for this purpose. One of these scores is the International Classification of Disease Injury Severity Score (ICISS). In contrast to other established scores, such as the Injury Severity Score (ISS), ICISS can be calculated based on injuries coded using ICD for administrative purposes, making it cost effective.
The validity of ICISS has primarily been studied in high-income countries ICISS requires an empirically estimated Survival Risk Ratio (SRR) for each ICD code. Some studies from high income countries has shown similar predictive performance of ICISS when using SRRs derived from other high-income countries. However, the generalisability of such SRRs to low- and middle-income countries such as India has not been researched. Therefore, the aim of this study was to validate an international version of ICISS in patients presenting with trauma to four public university hospitals in urban India.
Study design
Data from a multi-centre cohort study will be used.
Setting
Data from the Towards Improved Trauma Care Outcomes (TITCO) in India project will be used, which was conducted at four public university hospitals in urban India. The four centres were Lokmanya Tilak Municipal General Hospital in Mumbai, King Edward Memorial Hospital in Mumbai, Jai Prakash Narayan Apex Trauma Center in Delhi, and the Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital in Kolkata.
Data was collected between October 2013 and September 2015. Patient data was collected by one project officer in every study center. The project officer worked eight hour shifts per day, with a rotating schedule between day and night shifts. All project officers had at least a health science master degree, and were continuously trained and supervised by project management. Details on the data collection process has been published elsewhere.
Source and method of participant selection
Eligible patients were identified by project officers through direct observation in the emergency room and/or through extraction from patient records. Data from patients admitted outside of the shifts was collected retrospectively within days. Patients were followed up until discharge, death, or 30 days, whichever occurred first. Patients transferred to other hospitals were considered as discharged.
Covariates
The explanatory variable will be ICISS. Other covariates include age, sex, mechanism of injury, mode of transportation and transfer status. These covariates will be used to characterise the study sample.
Data sources/measurements
Patient outcomes was followed up at 30 days, death in hospital or discharge, whichever occurred first. Patients discharged alive before 30 days were considered to be alive at 30 days after arrival to the hospital. ICISS will be assigned based on ICD-coding of the free text injury descriptions, using the 10th revision of the World Health Organization's International Classification of Diseases (ICD-10). Survival Risk Ratios from two published data sets will be used. One of the data sets had SRRs calculated from an Australian and New Zealand population (14). The other had SRRs created by pooling data from Australia, Argentina, Austria, Canada, Denmark, New Zealand and Sweden (12). Final ICISS for patients with multiple injuries will be calculated by multiplying the SRRs for all ICD codes assigned to the patient.
Bias
All patients matching the selection criteria will be included in the study. All data was collected from patient records and examinations done by hospital personnel with no association to the study. The data collectors worked independently form the project managers. The free text injury descriptions will be extracted from the data set and assigned ICD-codes with no other data available, including data on patient outcome.
Study size
The sample size required is calculated to give an 80% power to detect substantial differences in model performance such as 1.5 times too high or low predicted survival probability. The calculations were based on published recommendations on the sample size needed to detect such differences in the external validity of prediction models with a binary outcome. Based on these recommendations, the sample size needed to include 100 consecutive events, i.e. in-hospital deaths within 24 hours and all non-events enrolled during the same period, was calculated. In-hospital mortality within 24 hours was used for the sample size calculation to power the study for secondary outcomes as well.
Quantitative variables
All quantitative variables will be analysed as continuous.
Statistical methods and analyses
R will be used for all statistical analyses. A confidence level of 95% and a significance level of 5% will be used. For each patient one ICISS will be calculated for each of the two sets of SRR referenced above. Henceforth, the ICISS based on SRR from Australia and New Zealand will be denoted ICISS-ANZ, and the ICISS based on the international SRR derived by Gedeborg et al. will be denoted ICISS-I. The performance of ICISS-ANZ and ICISS-I in predicting death within 30 days and death within 24 hours will be estimated in terms of discrimination and calibration.
The area under the receiver operating characteristics curve (AUROCC) will be used as a measure of discrimination. Calibration will be assessed visually by plotting observed versus predicted outcomes and will be quantified by calculating a calibration slope. The main analysis will be a complete case analysis in which only patients with complete data on outcomes and covariates will be included. Both ICISS-ANZ and ICISS-I will be based only on SRR calculated from ICD-10 codes that occurred in at least 20 patients in respective derivation dataset. Patients without any injury reported will be assigned an ICISS of 1.
Sensitivity analyses Four sensitivity analyses will be conducted. The first sensitivity analysis will include patients with missing data on covariates but with complete outcome data. The second sensitivity analysis will exclude patients without any reported injury. The third sensitivity analysis will include all SRR regardless of the number of occurrences in the original derivation datasets. In the final sensitivity analysis the ICISS for each patient will be based only on unique ICD-10 codes, in other words, each ICD-10 code was only allowed to contribute one SRR to ICISS even if it occurred more than once in the same patient.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| All participants | – | – |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The study population is patients admitted with a history of trauma in any of the study centers, or patients who died between arrival and admission. Patients who were dead on arrival to the hospital were excluded. Patients with isolated limb fractures without vascular injuries were excluded, due to the administration of these patients in the study centers.
Key inclusion criteria (1 listed)
- History of trauma or death between arrival and admission
Key exclusion criteria (1 listed)
- Isolated limb fractures without vascular injury
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Mortality
Time frame: Within 30 days of patient arrival to participating centre
1 secondary outcome
Mortality
Time frame: Within 24 hours of patient arrival to participating centre
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2017.
Related trials for Wounds and Injuries
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Not yet recruiting
Safety Study of Microlyte DualGuard
Wound Closure, Wound Care
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Wounds and Injuries, run by Martin Gerdin.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mortality (time frame: Within 30 days of patient arrival to participating centre). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2017.